Not finding it? Sign in to also search OpenAlex live.
-
Laves phase crystal analysis (LaCA): Atomistic identification of lattice defects in C14 and C15 topologically close-packed phases2021 Journal of materials research/Pratt's guide to venture capital sources article Engineering Intermetallics and Advanced Alloy Properties Open access
Zhuocheng Xie, Dimitri Chauraud, Erik Bitzek, Sandra Korte‐Kerzel, Julien Guénolé
17citations -
In-situ, near real-time ion beam analysis for depth-resolving changes in composition during oxidation of the Cr2AlC MAX phase2026 Nuclear Instruments and Methods in Physics Research Section B Beam Interactions with Materials and Atoms article Materials Science MXene and MAX Phase Materials Open access
Eleni Ntemou, Gyula U. L. Nagy, P. Pöllmann, Jochen M. Schneider, Daniel Primetzhofer
0citations -
2D vs. 3D phase analysis of an oxidized Cr2AlC coating2026 Materials Characterization article Engineering Advanced Materials Characterization Techniques Open access
Devi Janani Ramesh, Janis A. Sälker, Sameer Aman Salman, Eduardo G. Vega Halleslevens, Moritz to Baben, Christina Scheu, +1 more
0citations -
A systematic approach for quantitative orientation and phase fraction analysis of thin films through grazing-incidence X-ray diffraction2025 Journal of Applied Crystallography article Materials Science X-ray Diffraction in Crystallography Open access
Jorid Smets, Josef Simbrunner, Mario Fratschko, Víctor Rubio‐Giménez, Rob Ameloot, Hans‐Georg Steinrück, +1 more
5citations -
Cost-utility-analysis of molecular-integrated-profile for women with (high)intermediate risk endometrial cancer − PORTEC-4a an international, randomised, phase 3 trial2026 Radiotherapy and Oncology article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access
Anne Sophie V M van den Heerik, Nanda Horeweg, Marie A.D. Haverkort, Nienke Kuijsters, Stefan Kommoss, Friederike L.A. Koppe, +24 more
3citations -
1628MO A new benchmark for designing phase II trials for advanced or metastatic leiomyosarcoma (LMS) patients using progression free survival (PFS) as primary endpoint – an EORTC Soft Tissue and Bone Sarcoma Group (STBSG) meta-analysis
Georgios Kantidakis, Saskia Litière, Anouk Neven, Marie Vinches, Ian Robert Judson, Patrick Schöffski, +7 more
0citations -
7425 Biochemical Response, Symptom Control, and Safety of Oral Octreotide Capsules Treatment in Acromegaly: A Post Hoc Analysis of a Large Pooled Database from Three Phase 3 Clinical Trials2024 Journal of the Endocrine Society article Medicine Pituitary Gland Disorders and Treatments Open access
Maria Fleseriu, Susan Leanne Samson, Nienke Ruurdje Biermasz, Christian Joseph Strasburger, Shir Fuchs Orenbach, Jason A. Crompton, +1 more
0citations -
Antithrombotic Usage, Including Three-Year Outcomes With Dabigatran and Vitamin K Antagonists for Atrial Fibrillation, in Eastern Europe: A Descriptive Analysis From Phase 3 of the GLORIA-AF Registry2023 American Journal of Therapeutics article Medicine Atrial Fibrillation Management and Outcomes Open access
Jutta K Bergler-Klein, Nina N. Gotcheva, Oskars Kalējs, Zbigniew F. Kalarus, Dragan Kovačić, Viktor Peršić, +5 more
0citations -
Final Analysis Results and Patient-Reported Outcomes From DESTINY-Lung02—A Dose-Blinded, Randomized, Phase 2 Study of Trastuzumab Deruxtecan in Patients With HER2-Mutant Metastatic NSCLC
Pasi Antero Janne, Yasushi Goto, Toshio Kubo, Kiichiro Ninomiya, Sang‐We Kim, David Planchard, +13 more
35citations -
Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial2023 Annals of Hematology article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Steffen Koschmieder, Susanne Isfort, Lutz Jacobasch, Thomas Geer, Marcel Reiser, Michael Koenigsmann, +8 more
13citations -
Patient-reported outcomes in individuals with advanced gastrointestinal stromal tumor treated with ripretinib in the fourth-line setting: analysis from the phase 3 INVICTUS trial
Patrick Schöffski, Suzanne George, Michael Charles Heinrich, John Raymond Zalcberg, Sebastian Bauer, Hans A. J. Gelderblom, +12 more
10citations -
P271 To what extent are baseline characteristics in biologic-experienced patients with psoriatic arthritis associated with achievement of minimal disease activity at week 24 of guselkumab treatment: a post hoc analysis of the phase IIIb COSMOS clinical trial
William L. Tillett, Sarah Ohrndorf, Julio A. Ramírez, Marlies Neuhold, Robert Wapenaar, Elke Theander, +4 more
0citations